| Literature DB >> 23691513 |
Robert Schier1, Jochen Hinkelbein, Hanke Marcus, Ashley Smallwood, Arlene M Correa, Reza Mehran, Randa El-Zein, Bernhard Riedel.
Abstract
BACKGROUND: Perioperative vascular function has been widely studied using noninvasive techniques that measure reactive hyperemia as a surrogate marker of vascular function. However, studies are limited to a static setting with patients tested at rest. We hypothesized that exercise would increase reactive hyperemia as measured by digital thermal monitoring (DTM) in association to patients' cardiometabolic risk.Entities:
Mesh:
Year: 2013 PMID: 23691513 PMCID: PMC3652140 DOI: 10.1155/2013/837130
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Representative example of a temperature-time trace in response to occlusion-hyperemia.
Clinical characteristics.
|
| Mean (±SD) | Median (range) | |
|---|---|---|---|
| Age, y | 30 | 58 (±9.93) | 59 (45–70) |
| Height, m | 30 | 1.70 (±0.11) | 1.70 |
| Weight, kg | 30 | 83 (±18.62) | 81 |
| Waist, cm | 28 | 104 (±38.48) | 98 |
| BMI, (kg/m)2 | 30 | 28 (±4.76) | 28 |
| PreOp hemoglobin, mg/dL | 30 | 13 (±1.16) | 13 |
| PreOp fasting glucose, mg/dL | 30 | 103 (±24.63) | 100 |
| PreOp creatinine, mg/dL | 28 | 1.03 (±0.24) | 1.00 |
| Length of hospital stay, d | 30 | 12 (±13.91) | 7 |
| Length of ICU stay, d | 30 | 4 (±13.39) | 0 |
|
| |||
|
| |||
|
| |||
| Sex, female | 11 (37) | ||
| Obesity, | 10 (33) | ||
| Abdominal obesity, | 13 (46) | ||
| Smoker, | 21 (70) | ||
| Coronary artery disease**, | 1 (3) | ||
| Hypertension, | 13 (43) | ||
| Diabetes, | 4 (13) | ||
| Dyslipidemia, | 13 (43) | ||
| Statin therapy, | 5 (17) | ||
|
| 6 (20) | ||
| ACE-inhibitor therapy, | 4 (13) | ||
| ASA risk score > 2, | 28 (93) | ||
| Lee Cardiac Risk Index > 2, | 3 (10) | ||
| Chemotherapy,
| 13 (43) | ||
| Radiation therapy, | 10 (33) | ||
**Patient status after myocardial infarction (with or without intervention).
Reactive hyperemia (TR) before and after exercise.
| Before exercise | After exercise (10 min after) |
| |||||
|---|---|---|---|---|---|---|---|
|
| Mean | Std deviation |
| Mean | Std deviation | ||
| Starting temperature (°C) | 30 | 32.84 | 1.78 | 30 | 32.23 | 2.01 | 0.147 |
| Temperature rebound (TR°C) | 30 | 0.04 | 0.42 | 30 | 0.53 | 0.95 |
|
| Temperature rebound (TR%) | 30 | 0.14 | 1.27 | 30 | 1.78 | 3.29 |
|
| Area under curve after 15 sec | 30 | 14.89 | 4.70 | 30 | 11.92 | 5.26 |
|
| Area under curve after 30 sec | 30 | 29.01 | 9.04 | 30 | 23.29 | 10.23 |
|
| Area under curve after 45 sec | 30 | 41.50 | 12.86 | 30 | 33.34 | 14.53 |
|
| Area under curve after 60 sec | 30 | 52.11 | 16.15 | 30 | 41.85 | 18.12 |
|
| Heart rate (bpm) | 27 | 75 | 10.58 | 28 | 76 | 19.88 |
|
| Systolic blood pressure (mmHg) | 27 | 128 | 16.94 | 28 | 132 | 16.35 | 0.216 |
| Diastolic blood pressure (mmHg) | 27 | 76 | 6.09 | 28 | 79 | 9.06 | 0.081 |
| Mean blood pressure (mmHg) | 27 | 94 | 11.59 | 28 | 98 | 2.01 | 0.094 |
*Wilcoxon signed ranks test.
Figure 2Increase of reactive hyperemia (temperature rebound, TR%) 10 minutes after peak exercise.
Clinical characteristics and tertiles of TR % change after exercise (pre-/postexercise difference).
|
| Lower 2 tertiles | Upper tertiles |
| |
|---|---|---|---|---|
| Age, y | 30 | 57.5 ± 11.3 | 59.1 ± 6.7 | 0.685 |
| Sex, | 11 | 6 (55) | 5 (45) | 0.425 |
| Height, m | 30 | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.589 |
| Weight, kg | 30 | 84.5 ± 19.3 | 79.5 ± 17.8 | 0.501 |
| Waist, cm | 28 | 107.5 ± 46.2 | 95.9 ± 10.1 | 0.465 |
| BMI, (kg/m)2 | 30 | 28.8 ± 5.4 | 27.7 ± 3.3 | 0.567 |
| Obesity, | 10 | 8 (80) | 2 (20) | 0.419 |
| Abdominal obesity, | 13 | 8 (62) | 5 (38) | 0.505 |
| Smoker, | 21 | 12 (57) | 9 (43) | 0.204 |
| Coronary artery disease**, | 1 | 1 (100) | 0 (0) | 1.000 |
| Hypertension, | 13 | 11 (85) | 2 (15) | 0.119 |
| Diabetes, | 4 | 4 (100) | 0 (0) | 0.272 |
| Dyslipidemia, | 13 | 8 (62) | 5 (38) | 0.705 |
| Statin therapy, | 5 | 3 (60) | 2 (40) | 1.000 |
|
| 6 | 6 (100) | 0 (0) | 0.074 |
| Aspirin therapy, | 5 | 5 (100) | 0 (0) | 0.140 |
| ACE-inhibitor therapy, | 4 | 3 (75) | 1 (25) | 1.000 |
| ASA risk score > 2, | 28 | 19 (68) | 9 (32) | 0.615 |
| Lee Cardiac Risk Index > 2, | 3 | 3 (100) | 0 (0) | 0.107 |
| Chemotherapy, | 13 | 7 (54) | 6 (46) | 0.255 |
| Radiation therapy, | 10 | 7 (70) | 3 (30) | 0.101 |
| PreOp echo/EF, % | 17 | 61.4 ± 3.8 | 62.4 ± 6.9 | 0.709 |
| PreOp hemoglobin, mg/dL | 30 | 13.3 ± 1.0 | 13.5 ± 1.4 | 0.705 |
| PreOp fasting glucose, mg/dL | 30 | 106.7 ± 28.6 | 95.8 ± 12.0 | 0.260 |
| PreOp creatinine, mg/dL | 28 | 1.0 ± 0.3 | 1.0 ± 0.2 | 0.509 |
| Length of hospital stay, d | 30 | 11.2 ± 11.7 | 12.6 ± 18.32 | 0.800 |
| Length of ICU Stay, d | 30 | 2.4 ± 9.0 | 6.3 ± 19.9 | 0.462 |
*Fisher's exact test.
**Patient status after myocardial infarction (with or without intervention).